Genome and RNA sequencing for genetic diagnosis of early Parkinsonism
Part of Brain & nervous system clinical trials.
This study uses advanced genetic testing (genome and RNA sequencing) to find the genetic causes of Parkinsonism that starts before age 40 or runs in families. If you join, you will provide a blood sample and a small skin biopsy to help researchers understand your condition better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You developed Parkinsonism symptoms before age 40, or you have a family history of the condition.
- You have had a special brain scan (DaTscan) showing loss of dopamine nerve cells.
- Both your parents are alive and have previously stored DNA samples available for research.
- You are able to understand the study and give your signed consent.
- You have not already been diagnosed with a known genetic cause of Parkinsonism.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study builds a genetics “registry” of people diagnosed with Parkinson’s disease who agree to genetic testing. Your information may help researchers understand why Parkinson’s happens and improve future treatments.
This study is looking to improve how Parkinson’s and related brain conditions are identified and treated sooner. You may be asked to share your health information and provide blood or other samples, and possibly have procedures like a spinal fluid test or a small skin sample.
This trial studies genetic and biological samples from people with Parkinson's disease, their at-risk relatives, and healthy volunteers. It aims to find biomarkers that could help with earlier diagnosis and better treatments.
This study uses a new, advanced DNA sequencing method to look for a specific type of genetic change (called 'repeat expansion') that may cause neurological disorders. The goal is to help people who have a neurological condition but whose standard genetic tests did not find the cause.
This study uses a new DNA reading method to find hidden genetic causes of dystonia. It is for people with dystonia who had standard genetic testing that did not find a cause.
This study collects blood and related samples to create a “biobank” and uses lab tests to study genetic risk in Parkinson’s disease and idiopathic REM sleep behavior disorder (RBD). It may help researchers understand why symptoms develop and improve future prevention or treatment approaches.
Hear when a new Parkinson’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.